Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,927 | 141 | 80.4% |
| Travel and Lodging | $925.99 | 3 | 12.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $300.00 | 1 | 4.1% |
| Consulting Fee | $150.00 | 1 | 2.0% |
| Education | $51.00 | 1 | 0.7% |
| Gift | $19.40 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $1,536 | 43 | $0 (2024) |
| Alcon Laboratories Inc | $1,199 | 3 | $0 (2017) |
| Genentech USA, Inc. | $768.26 | 20 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $670.79 | 3 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $466.21 | 9 | $0 (2021) |
| ABBVIE INC. | $429.26 | 18 | $0 (2024) |
| Allergan, Inc. | $365.02 | 8 | $0 (2021) |
| Astellas Pharma US Inc | $316.27 | 8 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $228.67 | 11 | $0 (2024) |
| Alimera Sciences, Inc. | $209.42 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,452 | 39 | Regeneron Healthcare Solutions, Inc. ($497.60) |
| 2023 | $1,050 | 33 | Genentech USA, Inc. ($277.72) |
| 2022 | $559.53 | 21 | Genentech USA, Inc. ($178.58) |
| 2021 | $406.69 | 11 | Regeneron Healthcare Solutions, Inc. ($193.06) |
| 2020 | $462.10 | 11 | Regeneron Healthcare Solutions, Inc. ($188.37) |
| 2019 | $1,067 | 19 | Novartis Pharmaceuticals Corporation ($378.37) |
| 2018 | $294.62 | 5 | Carl Zeiss Meditec, Inc. ($135.94) |
| 2017 | $2,082 | 9 | Alcon Laboratories Inc ($1,199) |
All Payment Transactions
148 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: EYE CARE | ||||||
| 11/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $31.62 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/04/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $34.12 | General |
| Category: Ophthalmology | ||||||
| 10/29/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Ophthalmology | ||||||
| 10/22/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $111.79 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/09/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Ophthalmology | ||||||
| 10/07/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.79 | General |
| Category: EYE CARE | ||||||
| 09/23/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: EYE CARE | ||||||
| 09/16/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Ophthalmology | ||||||
| 08/27/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Ophthalmology | ||||||
| 08/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $109.23 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/29/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: EYE CARE | ||||||
| 07/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/24/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/07/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $31.79 | General |
| Category: Ophthalmology | ||||||
| 06/04/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/28/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: EYE CARE | ||||||
| 05/24/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/21/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 05/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 4,890 | 20,604 | $8.2M | $3.4M |
| 2022 | 16 | 3,486 | 10,799 | $4.8M | $2.0M |
| 2021 | 16 | 2,888 | 8,575 | $3.7M | $1.6M |
| 2020 | 13 | 1,890 | 5,602 | $2.3M | $958,313 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 305 | 3,762 | $5.2M | $2.6M | 50.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 398 | 2,153 | $1.3M | $191,298 | 14.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 556 | 1,930 | $379,662 | $124,642 | 32.8% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 15 | 4,020 | $176,290 | $116,768 | 66.2% |
| 92134 | Imaging of retina | Office | 2023 | 1,189 | 3,335 | $323,528 | $96,580 | 29.9% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 24 | 486 | $196,927 | $89,524 | 45.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 546 | 719 | $223,522 | $61,663 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 243 | 394 | $115,023 | $35,958 | 31.3% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 843 | 2,543 | $119,908 | $28,567 | 23.8% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 470 | 797 | $59,927 | $14,400 | 24.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 120 | 120 | $47,830 | $12,203 | 25.5% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 13 | 13 | $45,327 | $11,711 | 25.8% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 48 | 167 | $33,400 | $10,804 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 81 | 81 | $37,565 | $9,772 | 26.0% |
| J3490 | Unclassified drugs | Office | 2023 | 27 | 72 | $7,300 | $4,614 | 63.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $1,409 | $314.37 | 22.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 195 | 2,084 | $2.9M | $1.5M | 52.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 26 | 639 | $260,544 | $143,027 | 54.9% |
| 67028 | Injection of drug into eye | Office | 2022 | 277 | 1,326 | $769,368 | $118,815 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 409 | 1,224 | $241,056 | $79,638 | 33.0% |
| 92134 | Imaging of retina | Office | 2022 | 826 | 2,182 | $218,181 | $64,517 | 29.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 338 | 426 | $122,250 | $37,015 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 152 | 216 | $63,202 | $19,953 | 31.6% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 563 | 1,579 | $77,360 | $18,000 | 23.3% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 123 | 123 | $48,802 | $12,156 | 24.9% |
About Dr. Eric Feinstein, M.D
Dr. Eric Feinstein, M.D is a Ophthalmology healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1720340136.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Feinstein, M.D has received a total of $7,374 in payments from pharmaceutical and medical device companies, with $1,452 received in 2024. These payments were reported across 148 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,927).
As a Medicare-enrolled provider, Feinstein has provided services to 13,154 Medicare beneficiaries, totaling 45,580 services with total Medicare billing of $8.0M. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist, Retina Specialist
- Location Orlando, FL
- Active Since 06/12/2012
- Last Updated 07/05/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1720340136
Products in Payments
- EYLEA (Biological) $1,060
- OZURDEX (Drug) $771.21
- EYLEA HD (Biological) $546.13
- Vabysmo (Drug) $513.53
- Izervay (Drug) $241.27
- Syfovre (Drug) $207.08
- Cimerli (Biological) $178.71
- Iluvien (Biological) $142.00
- CIRRUS HD-OCT (Device) $135.94
- LUXTURNA (Biological) $117.29
- INVELTYS (Drug) $109.74
- SUSVIMO (Drug) $103.67
- ENVISTA TORIC (Device) $100.00
- Lucentis (Biological) $97.99
- Tecnis Multifocal Family of 1-piece IOLS (Device) $93.13
- ACTHAR (Biological) $90.20
- EVA, combined machine (Device) $71.01
- BEOVU (Drug) $67.78
- EVA Ophthalmic Surgical System (Device) $59.90
- VABYSMO (Drug) $53.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Orlando
Deepak Raja, M.d, M.D
Ophthalmology — Payments: $95,565
Mr. George Magruder, Md, MD
Ophthalmology — Payments: $38,091
Dr. Michael Shumski
Ophthalmology — Payments: $30,030
John Beneke, Md, MD
Ophthalmology — Payments: $24,028
Mr. Brian Haas, Md, MD
Ophthalmology — Payments: $12,582
Bradley Foster, M.d, M.D
Ophthalmology — Payments: $10,400